Myelo Therapeutics
UEI: G1LNCHNLYXF6
• CAGE: DP990
Overview
Awardee Type
Parent
Name
Myelo Therapeutics
Headquarters
Berlin
Germany
Germany
Most Recent Award
May 1, 2020
Calculating
Federal contract recipient
MYELO THERAPEUTICS GMBH
(UEI G1LNCHNLYXF6, CAGE DP990)
is headquartered in Berlin None.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The international organization
was founded in April 2013 and
federally registered in
October 2018.
Federal Award Analysis
Myelo Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
MYELO THERAPEUTICS GMBH
UEI
G1LNCHNLYXF6
CAGE Code
DP990
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
International Organization
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 18, 2013
Initial Registration
Oct. 16, 2018
Last Registration
Jan. 14, 2025
Registration Activation
Jan. 14, 2025
Registration Expiration
Jan. 14, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
Country of Incorporation
DEU
Employees
<500
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Myelo Therapeutics
Contract Awards
Myelo Therapeutics prime contract awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Myelo Therapeutics